116 related articles for article (PubMed ID: 9743496)
1. Inhibition of xenoreactive natural antibody production by retroviral gene therapy.
Bracy JL; Sachs DH; Iacomini J
Science; 1998 Sep; 281(5384):1845-7. PubMed ID: 9743496
[TBL] [Abstract][Full Text] [Related]
2. Induction of B-cell tolerance by retroviral gene therapy.
Bracy JL; Iacomini J
Blood; 2000 Nov; 96(9):3008-15. PubMed ID: 11049978
[TBL] [Abstract][Full Text] [Related]
3. Induction of molecular chimerism by gene therapy prevents antibody-mediated heart transplant rejection.
Bracy JL; Chase CM; Russell PS; Mauiyyedi S; Colvin RB; Iacomini J
Gene Ther; 2001 Nov; 8(22):1738-44. PubMed ID: 11892842
[TBL] [Abstract][Full Text] [Related]
4. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
5. The role of T cell help in the production of antibodies specific for Gal alpha 1-3Gal.
Cretin N; Bracy J; Hanson K; Iacomini J
J Immunol; 2002 Feb; 168(3):1479-83. PubMed ID: 11801692
[TBL] [Abstract][Full Text] [Related]
6. Engraftment of genetically modified bone marrow cells in sensitized hosts.
Bracy J; Iacomini J
Mol Ther; 2002 Aug; 6(2):252-7. PubMed ID: 12161192
[TBL] [Abstract][Full Text] [Related]
7. The α-Gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation.
Galili U
Biochimie; 2001 Jul; 83(7):557-63. PubMed ID: 11522383
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy to inhibit xenoantibody production using lentiviral vectors in non-human primates.
Fischer-Lougheed JY; Tarantal AF; Shulkin I; Mitsuhashi N; Kohn DB; Lee CC; Kearns-Jonker M
Gene Ther; 2007 Jan; 14(1):49-57. PubMed ID: 16886002
[TBL] [Abstract][Full Text] [Related]
9. Xenotransplantation: the importance of the Galalpha1,3Gal epitope in hyperacute vascular rejection.
Joziasse DH; Oriol R
Biochim Biophys Acta; 1999 Oct; 1455(2-3):403-18. PubMed ID: 10571028
[TBL] [Abstract][Full Text] [Related]
10. High antigen levels do not preclude B-cell tolerance induction to alpha1,3-Gal via mixed chimerism.
Haspot F; Bardwell PD; Zhao G; Sykes M
Xenotransplantation; 2008; 15(5):313-20. PubMed ID: 19134161
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
Huai G; Qi P; Yang H; Wang Y
Int J Mol Med; 2016 Jan; 37(1):11-20. PubMed ID: 26531137
[TBL] [Abstract][Full Text] [Related]
12. Use of lentiviral vectors to induce long-term tolerance to gal(+) heart grafts.
Kearns-Jonker M; Fischer-Lougheed J; Shulkin I; Kleihauer A; Mitsuhashi N; Kohn DB; Weinberg K; D'Apice AJ; Starnes VA; Cramer DV
Transplantation; 2004 Jun; 77(11):1748-54. PubMed ID: 15201677
[TBL] [Abstract][Full Text] [Related]
13. The desirable donor pig to eliminate all xenoreactive antigens.
Ladowski J; Martens G; Estrada J; Tector M; Tector J
Xenotransplantation; 2019 Jul; 26(4):e12504. PubMed ID: 30825348
[TBL] [Abstract][Full Text] [Related]
14. Xenoreactive natural antibodies.
Bracy JL; Cretin N; Cooper DK; Iacomini J
Cell Mol Life Sci; 1999 Dec; 56(11-12):1001-7. PubMed ID: 11212318
[TBL] [Abstract][Full Text] [Related]
15. Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues.
Inverardi L; Clissi B; Stolzer AL; Bender JR; Sandrin MS; Pardi R
Transplantation; 1997 May; 63(9):1318-30. PubMed ID: 9158028
[TBL] [Abstract][Full Text] [Related]
16. Decrease of human pancreatic cancer cell tumorigenicity by alpha1,3galactosyltransferase gene transfer.
Aubert M; Crotte C; Bernard JP; Lombardo D; Sadoulet MO; Mas E
Int J Cancer; 2003 Dec; 107(6):910-8. PubMed ID: 14601050
[TBL] [Abstract][Full Text] [Related]
17. Modifying the sugar icing on the transplantation cake.
Cooper DK
Glycobiology; 2016 Jun; 26(6):571-81. PubMed ID: 26935763
[TBL] [Abstract][Full Text] [Related]
18. Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy.
Larkin JM; Porter CD
Cancer Immunol Immunother; 2007 Jan; 56(1):60-9. PubMed ID: 16715304
[TBL] [Abstract][Full Text] [Related]
19. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses.
Naso F; Gandaglia A; Bottio T; Tarzia V; Nottle MB; d'Apice AJ; Cowan PJ; Cozzi E; Galli C; Lagutina I; Lazzari G; Iop L; Spina M; Gerosa G
Xenotransplantation; 2013; 20(4):252-61. PubMed ID: 23865597
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and limitations of cyclophosphamide-induced tolerance against alphaGal antigen.
Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Sueishi K; Nomoto K; Yasui H
Scand J Immunol; 2005 Sep; 62(3):271-80. PubMed ID: 16179014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
